NCT05824585
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05824585
Title DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dizal Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Research site New York New York 10065 United States Details
Research site Albury New South Wales Australia Details
Research site Ballarat Victoria Australia Details
Research site Melbourne Victoria Australia Details
Research site Perth Western Australia Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field